Medical Devices

The robotics firm completed crucial benchtop tests for its novel single-port system, a major step toward clinical use and challenging market leaders.

With improved financials and progress on therapies for cannabis use disorder and Down syndrome, the French biotech charts a confident course for the future.

The new DSP leverages 100% first-party HCP data, script-lift measurement, and sustainability metrics to offer unparalleled precision and performance.

A new 73-bed facility in Newark will create 122 jobs, expand services for an aging population, and set a new standard for rehabilitation in the region.

Phase 2 data for HRS/BHB-1893 show rapid efficacy and a simplified regimen, signaling a potential new era for treating hypertrophic cardiomyopathy.

With a fresh $6M infusion bringing its Series A to $36M, FIZE Medical is accelerating its global push for AI-powered, proactive fluid management in ICUs.

A new pocket-sized, AI-powered ultrasound aims to revolutionize prenatal care in Africa, putting life-saving diagnostics into the hands of local caregivers.

HistoSonics begins a landmark trial for a non-invasive BPH therapy that uses focused ultrasound to mechanically destroy tissue without incisions or heat.

A new drug not only reduces osteoarthritis pain significantly but may also be the first to modify the disease itself, a landmark study in The Lancet reveals.

After a transformative year with key FDA/EU approvals, Pulsenmore's financials get a one-time boost. Can it now conquer the remote prenatal care market?

LIB Therapeutics' new monthly, room-temperature stable cholesterol drug shows strong long-term data, challenging rivals with a focus on patient ease-of-use.

DERMAFLASH launches its first sonic dermaplaning system for pros, promising a safer, more effective alternative to traditional scalpel-based treatments.

Australian medtech firm 4DMedical lands CE Mark for its revolutionary CT:VQ lung imaging, fueling a major European expansion with a fresh AU$83M investment.

A Georgia firm's painless patch technology earns top honors, promising to revolutionize medicine delivery and solve critical global health challenges.

A $15M grant fuels a revolutionary therapy for a fatal childhood disease, turning patients' own cells into 'living biofactories' to fight MPS I.

After promising results in a key patient subgroup, the PREVAiLS study will test if pridopidine can slow the relentless progression of ALS.

After a major capital overhaul, PAVmed pivots to growth, advancing cancer diagnostics, remote monitoring, and a relaunched device portfolio.

NUCOT celebrates patients thriving 25+ years post-transplant, setting new global benchmarks in survival rates through advanced care and resilience.

A multimillion-dollar expansion in Springfield, MO will make Alltrista a leader in precision medical molding, creating jobs and fortifying supply chains.

Merz Aesthetics secures key EU approvals for its BELOTERO® Balance filler, offering a precise, evidence-backed solution for tired eyes and forehead lines.